Today's top medical abstracts
Oncology
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?

Home
General Oncology
For Practicing
Oncologists
Conferences
Jobs
Newsletters
My Library
Topics in
Oncology
        Alternative Therapies
        Anemia/Polycythemia
        BMT/SCT
        Basic Science/Genetics
        Bone/Cartilage
        Breast
        Carcinogenesis
        Coagulation/Bleeding Dz
        Colorectal Cancer/Polyps
        Dermatologic Oncology
        Diagnostics/Radiology
        Economics of Medicine
        Endocrine Oncology
        GI Oncology
        Gynecologic Oncology
        Head and Neck
        Hepatobiliary/Pancreas
        Leukemia/Lymphoma
        Lung/Thoracic Oncology
        Myeloproliferative Dz
        Neurologic Oncology
        Pain/Palliative Care
        Pediatric Heme/Oncology
        Pharmacology/Therapy
        Popular Press
        Renal/Urologic
        Side Effects
        Soft Tissue/Sarcoma
        Transfusion Medicine
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
 
Sponsor
For Practicing Oncologists
Improving Your Bottom Line: Is Your Practice Prepared for a Disaster?
Owen Dahl, Owen Dahl Consulting
Today's Oncology News: MCF2, A New Mitotic Checkpoint Control Point
D Scott Cunningham MD, PhD, MDLinx Oncology
Clinical Trial Watch: Trial Points to Cancer-Fighting Potential of IL-7
Tracy Hampton, PhD, MDLinx Oncology
  See all
olfactory neuroblastoma;microvessel density Article Summary

Click the title below to leave the MDLinx Network and go to the Journal's Website
Expression of bcl-2 is associated with microvessel density in olfactory neuroblastoma
Journal of Neuro-Oncology, 05/14/08
Print     Email This Article     Save in My Library   Free Abstract
Diensthuber M et al. – Expression of hypoxia-inducible factor (HIF)-1alpha, erythropoietin (Epo) expression, erythropoietin receptor (EpoR), and the anti-apoptotic protein bcl-2 may have a functional role in pathogenesis of olfactory neuroblastoma (ONB); bcl-2 may stimulate angiogenesis in ONB and may serve as a target for anti-angiogenic treatment in ONB

Methods

  • Immunohistochemical analysis of 20 ONB samples for expression of HIF-1alpha, Epo, EpoR by Epo, and bcl-2
  • Data correlated with microvessel density, proliferative activity, and apoptosis
  • Survival analysis for prognostic value of the examined factors

Results
  • HIF-1alpha, Epo, EpoR, and bcl-2 highly expressed in ONB
  • HIF-1alpha immunoreactivity in 90% of samples; bcl-2 immunoreactivity in 60%
  • Significant positive correlation between HIF-1alpha and bcl-2 expression and microvessel density
  • Survival analysis showed no prognostic significance for tested factors

 

--- BASIC SCIENCE/GENETICS TOP ARTICLES ---

Receive free subspecialty "5-minute updates" via email



 

Sponsor
--- NEUROLOGIC ONCOLOGY TOP ARTICLES ---

Receive free subspecialty "5-minute updates" via email



Sponsor
Read a Different Specialty
Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pediatrics
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology
Profession Index
Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2008 MDLinx, Inc.